Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer
Cancers · 07.04.2026 · 18 (7) · 1177
DOI: 10.3390/cancers18071177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 07.04.2026. Verfasst von Hirotaka Kashima und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japa…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arkray (Japan), ARKRAY, Inc..
Abstract (Originalsprache)
Backgrounds and Aim: Pancreatic cancer is frequently diagnosed at advanced stages, highlighting the need for biomarkers that are capable of detecting early-stage disease in asymptomatic individuals. Recently, apolipoprotein A2 isoforms (ApoA2-ATQ/AT) have been reported as a new blood biomarker for pancreatic cancer. We recently developed diagnostic models based on 100 highly expressed serum microRNAs (miRNAs) combined with CA19-9; these models achieved high accuracy in terms of distinguishing individuals with pancreatic cancer from healthy individuals. This study aimed to compare the diagnostic performance of these miRNA-based models with that of the ApoA2-ATQ/AT biomarker.
Methods
Comprehensive sequencing of serum miRNAs was conducted using samples from 120 pancreatic cancer patients recruited across 14 hospitals, along with 93 healthy controls without cancer. Serum CA19-9 levels, miRNA index values, miRNA+CA19-9 index values, and ApoA2 index values were assessed. miRNA-based indices were derived from classification models built on an automated machine-learning platform.
Results
The miRNA model (AUC 0.94; 95% CI 0.91–0.97) and the miRNA+CA19-9 model (AUC 0.99; 95% CI 0.98–1.00) outperformed ApoA2 (AUC 0.89; 95% CI 0.84–0.93) in terms of distinguishing individuals with pancreatic cancer from healthy controls across all stages. In early-stage disease (stages 0–I and 0–II), both miRNA-based models also demonstrated superior performance. Strong negative correlations were observed between the ApoA2 index and both the miRNA model index (r = −0.62) and the miRNA+CA19-9 index (r = −0.63).
Conclusions
These findings suggest that miRNA-based diagnostic models, particularly when combined with CA19-9, could serve as powerful tools for the early detection of pancreatic cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
- Research and Development Division, ARKRAY, Inc., Yousuien-nai, 59 Gansuin-cho, Kamigyo-ku, Kyoto 606-8507, Japan.
- Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
- Department of Gastroenterology and Hepatology, Japanese Red Cross Osaka Hospital, Osaka 543-8555, Japan.
- Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
- Department of Gastroenterology and Hepatology, Japanese Red Cross Wakayama Medical Center, Wakayama 640-8558, Japan.
ORCID-Profile: Hirotaka Kashima, Munenori Kawai, Kei Iimori, Munemasa Nagao, Mitsuharu Hirai, Masanori Asada, Toshihiro Morita, Shujiro Yazumi, Takuto Yoshioka, Tomonori Masuda, Akihisa Fukuda
Förderung
- Arkray (Japan)
- ARKRAY, Inc.
Zitieren
APA
Kashima, H., Kawai, M., Iimori, K., Nagao, M., Morikawa, T. J., Otomo, R., Hirai, M., Minaga, K., Asada, M., Umemura, A., Uenoyama, Y., Morita, T., Yazumi, S., Minami, R., Marui, S., Yamauchi, Y., Nakai, Y., Takada, Y., Shio, S., …, & Seno, H. (2026). Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Cancers, 18(7), 1177. https://doi.org/10.3390/cancers18071177
Vancouver
Kashima H, Kawai M, Iimori K, Nagao M, Morikawa TJ, Otomo R, et al. Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Cancers. 2026;18(7):1177. doi:10.3390/cancers18071177
BibTeX
@article{Kashima2026,
author = {Kashima, Hirotaka and Kawai, Munenori and Iimori, Kei and Nagao, Munemasa and Morikawa, Takamitsu J and Otomo, Ryo and Hirai, Mitsuharu and Minaga, Kosuke and Asada, Masanori and Umemura, Atsushi and Uenoyama, Yoshito and Morita, Toshihiro and Yazumi, Shujiro and Minami, Ryuki and Marui, Saiko and Yamauchi, Yuki and Nakai, Yoshitaka and Takada, Yutaka and Shio, Seiji and Yoshioka, Takuto and Kanda, Naoki and Masuda, Tomonori and Nagai, Kazuyuki and Hatano, Etsuro and Fukuda, Akihisa and Seno, Hiroshi},
title = {Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {7},
pages = {1177},
doi = {10.3390/cancers18071177}
}
EUVIMED